Eli Lilly to build $3.5 billion Pennsylvania plant in US manufacturing pushÂ

WASHINGTON, Jan 30 (Reuters) - Eli Lilly announced on Friday that it will build a pharmaceutical manufacturing facility in Pennsylvania, ​its fourth new site in an effort to expand ‌U.S. production and bolster medical supply chains. The $3.5 billion plant will make Lilly's injectable ‌weight-loss medications, including retatrutide, the company said in a statement. That next-generation obesity drug has outperformed Lilly's blockbuster drug Zepbound. Drugmakers are rushing to expand U.S. production as Pr ...